Literature DB >> 22708632

Tailoring of membrane proteins by alternative splicing of pre-mRNA.

Kathleen F Mittendorf1, Catherine L Deatherage, Melanie D Ohi, Charles R Sanders.   

Abstract

Alternative splicing (AS) of RNA is a key mechanism for diversification of the eukaryotic proteome. In this process, different mRNA transcripts can be produced through altered excision and/or inclusion of exons during processing of the pre-mRNA molecule. Since its discovery, AS has been shown to play roles in protein structure, function, and localization. Dysregulation of this process can result in disease phenotypes. Moreover, AS pathways are promising therapeutic targets for a number of diseases. Integral membrane proteins (MPs) represent a class of proteins that may be particularly amenable to regulation by alternative splicing because of the distinctive topological restraints associated with their folding, structure, trafficking, and function. Here, we review the impact of AS on MP form and function and the roles of AS in MP-related disorders such as Alzheimer's disease.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22708632      PMCID: PMC3448030          DOI: 10.1021/bi3007065

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  147 in total

1.  Assembly of the gamma-secretase complex involves early formation of an intermediate subcomplex of Aph-1 and nicastrin.

Authors:  Matthew J LaVoie; Patrick C Fraering; Beth L Ostaszewski; Wenjuan Ye; W Taylor Kimberly; Michael S Wolfe; Dennis J Selkoe
Journal:  J Biol Chem       Date:  2003-07-11       Impact factor: 5.157

2.  RNA secondary structure in mutually exclusive splicing.

Authors:  Yun Yang; Leilei Zhan; Wenjing Zhang; Feng Sun; Wenfeng Wang; Nan Tian; Jingpei Bi; Haitao Wang; Dike Shi; Yajian Jiang; Yaozhou Zhang; Yongfeng Jin
Journal:  Nat Struct Mol Biol       Date:  2011-01-09       Impact factor: 15.369

3.  Membrane-anchored aspartyl protease with Alzheimer's disease beta-secretase activity.

Authors:  R Yan; M J Bienkowski; M E Shuck; H Miao; M C Tory; A M Pauley; J R Brashier; N C Stratman; W R Mathews; A E Buhl; D B Carter; A G Tomasselli; L A Parodi; R L Heinrikson; M E Gurney
Journal:  Nature       Date:  1999-12-02       Impact factor: 49.962

4.  Purification and cloning of amyloid precursor protein beta-secretase from human brain.

Authors:  S Sinha; J P Anderson; R Barbour; G S Basi; R Caccavello; D Davis; M Doan; H F Dovey; N Frigon; J Hong; K Jacobson-Croak; N Jewett; P Keim; J Knops; I Lieberburg; M Power; H Tan; G Tatsuno; J Tung; D Schenk; P Seubert; S M Suomensaari; S Wang; D Walker; J Zhao; L McConlogue; V John
Journal:  Nature       Date:  1999-12-02       Impact factor: 49.962

5.  Aberrant regulation of insulin receptor alternative splicing is associated with insulin resistance in myotonic dystrophy.

Authors:  R S Savkur; A V Philips; T A Cooper
Journal:  Nat Genet       Date:  2001-09       Impact factor: 38.330

6.  Recruitment of human muscleblind proteins to (CUG)(n) expansions associated with myotonic dystrophy.

Authors:  J W Miller; C R Urbinati; P Teng-Umnuay; M G Stenberg; B J Byrne; C A Thornton; M S Swanson
Journal:  EMBO J       Date:  2000-09-01       Impact factor: 11.598

7.  Aberrant splicing in the presenilin-1 intron 4 mutation causes presenile Alzheimer's disease by increased Abeta42 secretion.

Authors:  C De Jonghe; M Cruts; E A Rogaeva; C Tysoe; A Singleton; H Vanderstichele; W Meschino; B Dermaut; I Vanderhoeven; H Backhovens; E Vanmechelen; C M Morris; J Hardy; D C Rubinsztein; P H St George-Hyslop; C Van Broeckhoven
Journal:  Hum Mol Genet       Date:  1999-08       Impact factor: 6.150

8.  Promotion of BACE1 mRNA alternative splicing reduces amyloid beta-peptide production.

Authors:  Karen R Mowrer; Michael S Wolfe
Journal:  J Biol Chem       Date:  2008-05-08       Impact factor: 5.157

9.  Spliced segments at the 5' terminus of adenovirus 2 late mRNA.

Authors:  S M Berget; C Moore; P A Sharp
Journal:  Proc Natl Acad Sci U S A       Date:  1977-08       Impact factor: 11.205

10.  A conserved GXXXG motif in APH-1 is critical for assembly and activity of the gamma-secretase complex.

Authors:  Sheu-Fen Lee; Sanjiv Shah; Cong Yu; W Christian Wigley; Harry Li; Myungsil Lim; Kia Pedersen; Weiping Han; Philip Thomas; Johan Lundkvist; Yi-Heng Hao; Gang Yu
Journal:  J Biol Chem       Date:  2003-11-19       Impact factor: 5.157

View more
  13 in total

1.  Revisiting the identification of canonical splice isoforms through integration of functional genomics and proteomics evidence.

Authors:  Hong-Dong Li; Rajasree Menon; Gilbert S Omenn; Yuanfang Guan
Journal:  Proteomics       Date:  2014-11-17       Impact factor: 3.984

2.  DeepIsoFun: a deep domain adaptation approach to predict isoform functions.

Authors:  Dipan Shaw; Hao Chen; Tao Jiang
Journal:  Bioinformatics       Date:  2019-08-01       Impact factor: 6.937

Review 3.  The determinants of alternative RNA splicing in human cells.

Authors:  Tatsiana V Ramanouskaya; Vasily V Grinev
Journal:  Mol Genet Genomics       Date:  2017-07-13       Impact factor: 3.291

4.  DNA signals at isoform promoters.

Authors:  Zhiming Dai; Yuanyan Xiong; Xianhua Dai
Journal:  Sci Rep       Date:  2016-06-29       Impact factor: 4.379

5.  JMJD6 promotes melanoma carcinogenesis through regulation of the alternative splicing of PAK1, a key MAPK signaling component.

Authors:  Xujun Liu; Wenzhe Si; Xinhua Liu; Lin He; Jie Ren; Ziran Yang; Jianguo Yang; Wanjin Li; Shumeng Liu; Fei Pei; Xiaohan Yang; Luyang Sun
Journal:  Mol Cancer       Date:  2017-11-29       Impact factor: 27.401

Review 6.  Alternative RNA splicing: contribution to pain and potential therapeutic strategy.

Authors:  Lucy F Donaldson; Nicholas Beazley-Long
Journal:  Drug Discov Today       Date:  2016-06-18       Impact factor: 7.851

Review 7.  Diversification of the muscle proteome through alternative splicing.

Authors:  Kiran Nakka; Claudia Ghigna; Davide Gabellini; F Jeffrey Dilworth
Journal:  Skelet Muscle       Date:  2018-03-06       Impact factor: 4.912

Review 8.  Alternative splicing for diseases, cancers, drugs, and databases.

Authors:  Jen-Yang Tang; Jin-Ching Lee; Ming-Feng Hou; Chun-Lin Wang; Chien-Chi Chen; Hurng-Wern Huang; Hsueh-Wei Chang
Journal:  ScientificWorldJournal       Date:  2013-05-22

9.  Systematically differentiating functions for alternatively spliced isoforms through integrating RNA-seq data.

Authors:  Ridvan Eksi; Hong-Dong Li; Rajasree Menon; Yuchen Wen; Gilbert S Omenn; Matthias Kretzler; Yuanfang Guan
Journal:  PLoS Comput Biol       Date:  2013-11-07       Impact factor: 4.475

10.  Extent of pre-translational regulation for the control of nucleocytoplasmic protein localization.

Authors:  Mikael-Jonathan Luce; Anna Akuvi Akpawu; Daniel C Tucunduva; Spencer Mason; Michelle S Scott
Journal:  BMC Genomics       Date:  2016-06-24       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.